NCCIH co-sponsored a recent workshop that united two of its research priorities: natural products and pain. Learn more here.
NCCIH Research Blog
Blog Posts Category
NCCIH blogs about research developments related to complementary health practices. Check in regularly to keep up with the latest findings.
NCCIH Deputy Director Dr. David Shurtleff discusses a recent NCCIH-sponsored symposium on cannabinoid research in this blog post.
New funding opportunity announcements present opportunities for new research related to botanicals and natural products. Find out more here.
Learn more about an upcoming workshop (co-sponsored by NCCIH) on natural products and pain research.
In this blog post, Dr. Craig Hopp addresses an upcoming natural products clinical trials workshop scheduled for September 13-14 at NIH in Bethesda, Md.
In this blog post, Dr. Craig Hopp discusses NCCIH’s focus on natural products research.
Illnesses and deaths linked to tobacco smoking are a huge public health problem in the United States and worldwide. Although treatments such as counseling and medication are available to help people stop smoking, research indicates that these treatments are not always available or successful for every patient, and that an individualized approach is desirable.
Find out more about a new series of funding opportunity announcements for investigator-initiated clinical trials, and register for this May 9 webinar: New NCCIH Funding Opportunities for Natural Products Clinical Trials.
Over the years, I have often been asked whether the National Center for Complementary and Integrative Health (NCCIH) will fund clinical trials of natural products. The answer is, “Yes.” NCCIH funds clinical research of natural products, including herbal products, botanicals, products marketed as dietary supplements, and probiotics.
In this research blog post,
In this blog post, Dr. Craig Hopp speaks to the necessity of using high-impact research approaches to uncover the biological signatures of complex natural products.
This blog post announces the upcoming NIH event: “Marijuana and Cannabinoids: A Neuroscience Research Summit” to be held March 22-23, 2016.
Dr. Claire Fraser’s NIH lecture on the functional dynamics of the gut microbiome in health and disease is now available online. In her talk, Dr. Fraser focused on the intriguing possibility that the gut microbiota may play an important role in response to vaccines and susceptibility to enteric pathogens.
Dr. Craig Hopp announces NCCIH’s grant for a new Center of Excellence for Natural Product Drug Interaction Research in this blog post.
In this blog post. Dr. John Williamson describes intriguing cutting-edge research on the development of anti-HIV drugs from natural products.
NCCIH Director Dr. Josephine Briggs discusses the difference between correlation and causation, as illustrated by a recent study on chamomile, in this blog post.
In this blog post, NCCAM Program Director Dr. Craig Hopp announces an informational webinar for applicants for the Center of Excellence for Natural Product Drug Interaction Research.
I have an exciting new funding opportunity announcement (FOA) to tell you about: the “Center for Advancing Natural Products Innovation and Technology (U41),” or RFA-AT-14-006. This grant is part of a diverse portfolio of projects on natural products research cosponsored by NCCAM and the NIH Office of Dietary Supplements (ODS). The goal of this FOA is to improve upon and strengthen the technologies and methods used in natural-products research—leading to better understanding of the biology and chemistry of natural products and how they impact health and wellness.
On September 9, NCCAM was pleased to host Patricia Hibberd, M.D., Ph.D., who delivered a lecture at NIH on “Probiotics, the Microbiome, and Host Immune Response: Insights for Novel Therapeutic Approaches.” Dr. Hibberd is professor of pediatrics at Harvard Medical School, and chief of the Division of Global Health at Massachusetts General Hospital for Children, as well as professor of global health at Harvard School of Public Health.
At NCCAM, one of the interesting things we are doing with respect to natural products is moving ahead on a plan for systematic evaluation of the ways in which they interact with prescription medications.
Dietary supplements such as herbs and botanicals are popular complementary health approaches. A new study in JAMA Internal Medicine, led by Regan Bailey, Ph.D., R.D., and her colleagues at the NIH Office of Dietary Supplements (ODS), used data from the National Health and Nutrition Examination Survey (NHANES) to figure out why.
Last month, Dr. David Kingston delivered the Stephen E. Straus Distinguished Lecture in the Science of Complementary Health Therapies. Immediately following his talk, titled Natural Products: Drugs and Medicines for All Reasons and All Seasons, he sat down with NCCAM Deputy Director Jack Killen to discuss the future of natural products research. Highlights are posted here.
This week, one of the most e-mailed articles on The New York Times Web site was its Well blog, which discussed how grapefruit is responsible for many drug reactions. We’re learning that the chemical constituents within grapefruit affect the bioavailability of many drugs, including some cholesterol, high blood pressure, and anti-cancer drugs—as well as some opiates, birth control pills, and many other medications.
Recently, six of NCCAM’s outstanding natural products research grantees were invited to present posters following the 2012 Stephen E. Straus Distinguished Lecture in the Science of Complementary Health Therapies delivered by David Kingston, Ph.D. Their research presentations were a small sample of the importance and scientific merit of natural products research supported by NCCAM, and they complemented Dr. Kingston’s talk.